Is HLA-E with its receptors an immune checkpoint or an antigenic determinant in allo-HCT?
{{output}}
Hematopoietic cell transplantation (HCT) represents a potentially curative therapeutic approach for various hematologic and non-hematologic malignancies. Human leukocyte antigen (HLA) matching is still the central selection criterion for HCT donors. Neverthele... ...
